Navigation Links
Maximizing the Potential of Multi-Drug Portfolios Without Cannibalizing from a Legacy Brand
Date:12/10/2010

earch included 28 respondents at 22 leading pharmaceutical, biotech and medical device companies. Research analysts also conducted in-depth interviews to collect executive insights and harvest best practices and lessons learned.

To learn more about this report, download a complimentary report excerpt at http://www3.best-in-class.com/rr1035.htm. For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/. 

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. 


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
2. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
3. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
4. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
5. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
6. Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
7. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
8. Potential Breakthrough Cancer Treatment Emerges from MIPS-Funded Clinical Trial Teaming CSA Medical Inc. and University of Maryland Researchers
9. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
10. Potential Early Warning System for Lung Cancer Identified
11. Preclinical Studies Show Potential Progress Toward Identifying Specific Tumor Types With Higher Likelihood of Demonstrating Response to Anti-Cancer Compounds Early in Clinical Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... -- MarketReportsOnline.com announces addition of new market research ... Edition Material and Clinical Trial Requirements of Application ... of Registration Application for Imported Traditional Chinese Medicines ... The traditional medicines in Orient, especially, ... occidental as mysterious medicines. Until today not only ...
(Date:5/22/2013)... SAN FRANCISCO, Calif. , May 22, 2013 /PRNewswire/ ... today announced the clinical advancement of three programs in ... formulation of a JAK/SYK inhibitor, R348, being developed by ... other two programs are aimed at oncology targets and ... kinase inhibitor under development by BerGenBio AS (BerGenBio) and ...
(Date:5/22/2013)... , May 22, 2013 PRNewswire ... the production of a vaccine candidate for the ... third party laboratory using the iBioLaunch™ platform. This ... measured from initial antigen sequence information to purification ... http://photos.prnewswire.com/prnh/20120419/NY91086LOGO ) The iBioLaunch platform ...
Breaking Medicine Technology:China Pharmaceutical Market Guidebook Series (4) 2013 Report 2China Pharmaceutical Market Guidebook Series (4) 2013 Report 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 4China Pharmaceutical Market Guidebook Series (4) 2013 Report 5Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 2Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 3Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 4iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza 2
... RGEN ) announced today that the Company ... the use of RG1068, synthetic human secretin, to,improve ... resonance,imaging (MRI). This Phase 3 study is a ... patients will receive an,unenhanced MRI followed by a ...
... Type 2 Diabetes -, HAYWARD, Calif., March ... the discovery and development of,proprietary new medicines for ... has dosed the first cohort of healthy subjects ... potential first-in-class treatment,for type 2 diabetes., The ...
Cached Medicine Technology:Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging 2Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging 3Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging 4Metabolex Initiates Phase 1 Trial of MBX-2982 2
(Date:5/22/2013)... City, NJ (PRWEB) May 22, 2013 ... compliance, and management solutions for social enterprise collaboration ... LLC, a consulting firm based in Chicago, Ill. ... integrate their products and provide best-in-class solutions for ... and improve collaboration. , AvePoint’s DocAve Software ...
(Date:5/22/2013)... 22, 2013 BroadConnect Telecom, the ... IT security solutions in North America announced plans ... its newest BroadConnect hosted security solutions. Available on ... combination, BroadConnect’s new Security as a Service (SaaS) ... Internet connection of their choice, while optimizing internal ...
(Date:5/22/2013)... May 22, 2013 Asthma, a disorder ... and swell causes wheezing, shortness of breath, chest tightness ... occurs, the muscles surrounding the airways become tight and ... amount of air that can pass. Asthma attacks can ... airflow is severely restricted. Reuters reports that ...
(Date:5/22/2013)... May 22, 2013 Many people across ... for education on how to lose weight safely and ... challenging and may demotivate people to continue their journey ... discussed this week on Medical News Today ... to lose weight and actually losing those initial pounds ...
(Date:5/22/2013)... Poor adherence to appropriate medication therapy has been ... death (some 125,000 deaths in the U.S. every year ... It’s been estimated that between 33% and 69% of ... adherence — a reality that costs the American health-care ... is the degree of medication non-adherence — and the ...
Breaking Medicine News(10 mins):Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3Health News:BroadConnect Telecom to Launch Enterprise-Grade Hosted Security Solutions Engineered to Meet the Demands of Real World Business 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce New hCG Diet Plans That May Reduce the Severity of Asthma Attacks 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce New hCG Diet Plans That May Reduce the Severity of Asthma Attacks 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Break the Cycle of Obesity and Weight Gain With New Education For Patients on How to Lose Weight the Healthy Way 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Break the Cycle of Obesity and Weight Gain With New Education For Patients on How to Lose Weight the Healthy Way 3Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2
... use of Zetia and ... Vytorin., ... Jersey appointed Hagens Berman, along with four other firms, co-counsel,in a case ... which,claims the companies knowingly misled consumers on the use of popular,prescription drugs ...
... Senators John McCain, Hillary Clinton and Barack Obama all ... terror" as they campaigned across the U.S. this year. ... be treated to a psychological perspective of the candidates, ... Meeting. Attendees of the Presidential Symposium will hear ...
... Study found doctors with patients of both races still showed ... New research shows that black patients with diabetes tend to ... the same doctor. , In other words, the gap can,t ... care. Racial disparities in diabetes care appear to be more ...
... Sysmex America, Inc. (SAI),today announced the ... (SNCS) at Hagerstown Medical Laboratory, Maryland.,SNCS is ... continuously collects,and tracks instrument performance data from ... and Support. SNCS enables proactive response to ...
... Disappear or be Hindered For ... California,s Most Vulnerable Citizens, SACRAMENTO, Calif., June 10 ... California Department of,Health Care Services and its director Sandra Shewry ... going into effect on July 1,2008. The action claims that ...
... Entertainment & Year Round Events Collaborate on Raising Awareness ... and Funding for Breast Cancer Research & Education, ... today announced,the formation of a new multilevel branding initiative, ... and events, with a,percentage of the sales earmarked for ...
Cached Medicine News:Health News:Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck 2Health News:Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck 3Health News:The forever war on terror: Dilemmas and choices 2Health News:No Matter the Doctor, Black Diabetics Fare Worse Than White Counterparts 2Health News:No Matter the Doctor, Black Diabetics Fare Worse Than White Counterparts 3Health News:Sysmex America to Enable Prolonged Hematology Instrument Uptime for Hagerstown Medical Laboratory With 1,000th SNCS Activation 2Health News:Sysmex America to Enable Prolonged Hematology Instrument Uptime for Hagerstown Medical Laboratory With 1,000th SNCS Activation 3Health News:Eight California Pharmacies File Lawsuit Against the California Department of Health Care Services to Stop the 10 Percent Medi-Cal Provider Cuts to Pharmacies 2Health News:PiNKiTUDE, New Cause Marketing Initiative Inspired by MGM's Pink Panther, Benefits Susan G. Komen for the Cure(R) 2Health News:PiNKiTUDE, New Cause Marketing Initiative Inspired by MGM's Pink Panther, Benefits Susan G. Komen for the Cure(R) 3Health News:PiNKiTUDE, New Cause Marketing Initiative Inspired by MGM's Pink Panther, Benefits Susan G. Komen for the Cure(R) 4
We offer small and large pre-gelled Surface Electrodes suitable for EGG or EMG recordings. Surface Electrodes, Skin Preparation and Conductive Cream complete the setup for a EGG study and are essenti...
We offer small and large pre-gelled Surface Electrodes suitable for EGG or EMG recordings. Surface Electrodes, Skin Preparation and Conductive Cream complete the setup for a EGG study and are essenti...
We offer small and large pre-gelled Surface Electrodes suitable for EGG or EMG recordings. Surface Electrodes, Skin Preparation and Conductive Cream complete the setup for a EGG study and are essenti...
Sandhill Scientific offers a comprehensive selection of solid state and water perfused catheters for both adult & pediatric applications.Contact Sandhill Scientific for full details...
Medicine Products: